MAI Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.9M | Sell |
70,346
-27,812
| -28% | -$3.52M | 0.06% | 254 |
|
2025
Q1 | $12.6M | Buy |
98,158
+3,923
| +4% | +$502K | 0.09% | 189 |
|
2024
Q4 | $12.5M | Buy |
94,235
+4,833
| +5% | +$639K | 0.09% | 182 |
|
2024
Q3 | $13M | Sell |
89,402
-1,081
| -1% | -$157K | 0.12% | 132 |
|
2024
Q2 | $12.4M | Buy |
90,483
+33,844
| +60% | +$4.65M | 0.12% | 133 |
|
2024
Q1 | $7.77M | Sell |
56,639
-924
| -2% | -$127K | 0.08% | 196 |
|
2023
Q4 | $7.82M | Sell |
57,563
-6,679
| -10% | -$907K | 0.1% | 159 |
|
2023
Q3 | $7.86M | Sell |
64,242
-1,471
| -2% | -$180K | 0.12% | 154 |
|
2023
Q2 | $8.34M | Sell |
65,713
-2,171
| -3% | -$276K | 0.12% | 148 |
|
2023
Q1 | $8.77M | Buy |
67,884
+1,054
| +2% | +$136K | 0.14% | 138 |
|
2022
Q4 | $8.77M | Buy |
66,830
+2,776
| +4% | +$364K | 0.15% | 132 |
|
2022
Q3 | $7.49M | Buy |
64,054
+6,535
| +11% | +$764K | 0.14% | 138 |
|
2022
Q2 | $6.77M | Buy |
57,519
+17,160
| +43% | +$2.02M | 0.13% | 133 |
|
2022
Q1 | $5.26M | Sell |
40,359
-5,503
| -12% | -$717K | 0.09% | 163 |
|
2021
Q4 | $7M | Buy |
45,862
+32,221
| +236% | +$4.92M | 0.11% | 145 |
|
2021
Q3 | $2.21M | Buy |
13,641
+10,511
| +336% | +$1.7M | 0.04% | 210 |
|
2021
Q2 | $512K | Buy |
3,130
+246
| +9% | +$40.2K | 0.01% | 474 |
|
2021
Q1 | $434K | Buy |
2,884
+765
| +36% | +$115K | 0.01% | 481 |
|
2020
Q4 | $321K | Sell |
2,119
-20
| -0.9% | -$3.03K | 0.01% | 503 |
|
2020
Q3 | $290K | Buy |
2,139
+22
| +1% | +$2.98K | 0.01% | 447 |
|
2020
Q2 | $289K | Buy |
+2,117
| New | +$289K | 0.01% | 431 |
|
2018
Q1 | – | Sell |
-3,186
| Closed | -$340K | – | 471 |
|
2017
Q4 | $340K | Buy |
3,186
+78
| +3% | +$8.32K | 0.02% | 329 |
|
2017
Q3 | $346K | Buy |
3,108
+90
| +3% | +$10K | 0.02% | 309 |
|
2017
Q2 | $312K | Hold |
3,018
| – | – | 0.02% | 335 |
|
2017
Q1 | $295K | Sell |
3,018
-10,152
| -77% | -$992K | 0.02% | 338 |
|
2016
Q4 | $1.17M | Buy |
13,170
+3,342
| +34% | +$296K | 0.08% | 168 |
|
2016
Q3 | $948K | Buy |
9,828
+282
| +3% | +$27.2K | 0.07% | 183 |
|
2016
Q2 | $819K | Buy |
9,546
+120
| +1% | +$10.3K | 0.06% | 204 |
|
2016
Q1 | $819K | Buy |
9,426
+930
| +11% | +$80.8K | 0.06% | 204 |
|
2015
Q4 | $958K | Buy |
8,496
+435
| +5% | +$49.1K | 0.07% | 180 |
|
2015
Q3 | $815K | Buy |
8,061
+2,907
| +56% | +$294K | 0.06% | 217 |
|
2015
Q2 | $634K | Buy |
+5,154
| New | +$634K | 0.04% | 272 |
|